Cell and Gene Therapy
🌏 NMPANMPA news and analysis for pharmaceutical BD, investment, and market access
Articles about Cell and Gene Therapy
Showing 1–4 of 4 articles
Quick answer
NovaPharmaNews Cell and Gene Therapy hub for NMPA covers 4 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
NMPA Drug Approvals Surge in 2025: Record 61 First Global Approvals Signal Accelerated Market Access
Cell and Gene Therapy Approvals in China: Latest Regulatory Updates
Cryoport Q1 2026 Results: Revenue Jumps 26% Supporting Record 766 Clinical Trials and 21 Commercial Cell Gene Therapies
ChinaBio Partnering Forum: Biotech Deals & APAC Innovation
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.